REFILE-BRIEF-Diamyd Medical increases investment in stem cell activity – Reuters
|
REFILE-BRIEF-Diamyd Medical increases investment in stem cell activity
Reuters Increases investment in stem cell activity. * Says invests an additional 0.8 million Swedish crowns ($93,134) in Cellaviva AB, a Swedish commercial biobank for stem cells Source text for Eikon: Further company coverage: ($1 = 8.5898 Swedish crowns) … |
